Purinergic P1 Receptor Antagonists
"Purinergic P1 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.
| Descriptor ID |
D058915
|
| MeSH Number(s) |
D27.505.519.625.725.400.100 D27.505.696.577.725.400.100
|
| Concept/Terms |
Purinergic P1 Receptor Antagonists- Purinergic P1 Receptor Antagonists
- P1 Purinoceptor Antagonists
- Antagonists, P1 Purinoceptor
- Purinoceptor Antagonists, P1
- Adenosine Receptor Antagonists
- Antagonists, Adenosine Receptor
- Receptor Antagonists, Adenosine
|
Below are MeSH descriptors whose meaning is more general than "Purinergic P1 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Purinergic P1 Receptor Antagonists".
This graph shows the total number of publications written about "Purinergic P1 Receptor Antagonists" by people in this website by year, and whether "Purinergic P1 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Purinergic P1 Receptor Antagonists" by people in Profiles.
-
Disagreement between splenic switch-off and myocardial T1-mapping after caffeine intake. Int J Cardiovasc Imaging. 2018 Apr; 34(4):625-632.
-
Beneficial effects of theophylline infusions in surgical patients with intra-abdominal hypertension. Langenbecks Arch Surg. 2011 Aug; 396(6):793-800.
-
Rational use of diuretics in acute decompensated heart failure. Curr Heart Fail Rep. 2008 Sep; 5(3):153-62.
-
Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res. 2005 Jul 01; 67(1):124-33.
-
Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure. J Am Coll Surg. 2002 May; 194(5):603-9.
-
Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol. 2001 May; 21(5):791-6.
-
Contributions of adenosine receptor activation to the ocular actions of epinephrine. Invest Ophthalmol Vis Sci. 1999 Aug; 40(9):2054-61.
-
Characterization of ocular hypertension induced by adenosine agonists. Invest Ophthalmol Vis Sci. 1996 Aug; 37(9):1833-9.